Key result
Identified acute heart failure precipitants show no association with 30-day outcomes.
Why the study?
There are limited studies on acute heart failure precipitants and their relationship with outcomes in patients with chronic heart failure.
Cohort (n=185)
No
Answers are grounded in this paper and cite their sources.
Nonadherence predominated among identified precipitants; observational data leave open whether targeting them improves 30-day outcomes.
OBJECTIVES: To identify acute heart failure (HF) precipitants in patients with a history of chronic HF, and to analyse any relationship with early outcomes. BACKGROUND: There are limited studies on acute HF precipitants and the relationship with outcomes, and determining this will help to identify the avoidable precipitants and may lead to better outcomes. METHODS: Patients with a history of HF and admission to the authors' hospital in 2008, with a discharge primary diagnosis of HF, were enrolled. Diagnosis of HF was prospectively defined and reviewed by two cardiology teams. Patients' case records were reviewed, or families were interviewed for 1-month follow-up outcome information. RESULTS: 242 admissions by 185 patients constituted our study cohort. Patients were older, and 36.8% were females. The ethnic Chinese, Malay and Indian composition of the cohort were 41.3%, 35.1% and 16.1% respectively. The mean left-ventricular ejection fraction was 34.0±17.5%. Preserved left ventricular ejection fraction (≥45%) constituted 35.1% of the cohort. Acute HF precipitants were identified in 62.8% of admissions and unidentified in 37.2% admissions. Non-compliance issues and infections constituted 27.2% and 13.6% of precipitants respectively. Cardiac precipitants accounted for 10.0% admissions. Multiple precipitants accounted for 8.3% admissions. There were no significant differences in patient profile, including ethnicity and gender, and outcomes between patients with identified precipitants and patients with unidentified precipitants. CONCLUSION: Non-compliance issues were a major precipitant of acute HF in patients with chronic HF. Precipitants were not determined in 37.2% of admissions. There were no significant associations between the different types of precipitants and early 30-day outcomes.
No takes yet. Share an insight, caveat, or question.
Leong et al. (2011) conducted a cohort in Acute heart failure (n=185). Identified acute heart failure precipitants vs. Unidentified precipitants was evaluated on Early 30-day outcomes. Identified acute heart failure precipitants, present in 62.8% of admissions with non-compliance being the most common (27.2%), had no significant association with early 30-day outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: